|
|
(2 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
| __NOTOC__ | | __NOTOC__ |
| *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
− | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper]
| |
− | {{tp|p=32036011|t=ä. Coronavirus infections reported by ProMED, February 2000?January 2020 |pdf=|usr=}}
| |
− | {{tp|p=23202522|t=2012. Virus Pathogen Database and Analysis Resource (ViPR): A Comprehensive Bioinformatics Database and Analysis Resource for the Coronavirus Research Community |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
− | *[https://www.newsweek.com/russia-developing-coronavirus-treatment-that-disinfects-body-uv-light-inside-1508350 uv emitting particles to be inhaled under dev in Russia]
| |
| | | |
| *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
− | {{tp|p=C7138902|t=ä. Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019?2020 |pdf=|usr=}}
| |
− | {{tp|p=32265372|t=2020. Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature |pdf=|usr=}}
| |
− | {{tp|p=32355445|t=2020. Pistes urgentes ...|pdf=|usr=}}''reviews this&that worth looking in, reviews complement
| |
− | {{tp|p=32173256|t=2020. SARS Coronavirus Redux |pdf=|usr=}}
| |
− | {{tp|p=32313824|t=ä. Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives |pdf=|usr=}}
| |
− |
| |
− |
| |
− |
| |
| *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| | | |
Zeile 25: |
Zeile 13: |
| | | |
| *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
− | {{tp|p=32380210|t=2020. The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19 |pdf=|usr=}}
| + | |
| | | |
| *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
− | {{tp|p=32487445|t=ä. ... 18F-FDG-PET-TC case... |pdf=|usr=}}
| |
− | {{tp|p=32451194|t=ä. Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32409232|t=ä. Lung Ultrasound in Children with COVID-19: Preliminary Findings |pdf=|usr=}}
| |
− | {{tp|p=32288853|t=2020. 2019-nCoV-Pneumonie ähnelt radiologisch SARS und MERS |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Diagnosis (other modalities)]]''' | | *'''[[Diagnosis (other modalities)]]''' |
− | {{tp|p=32421627|t=2020. The impact of biosensing in a pandemic outbreak: COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 41: |
Zeile 23: |
| | | |
| *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
− | {{tp|p=32296735|t=2020. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus |pdf=|usr=}}
| |
− | {{tp|p=32402329|t=2020. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses |pdf=|usr=}}
| |
− | {{tp|p=32452417|t=2020. New insights into the evolutionary features of viral overlapping genes by discriminant analysis |pdf=|usr=}}
| |
− | {{tp|p=C7197565|t=ä. No evidence for distinct types in the evolution of SARS-CoV-2 |pdf=|usr=}}
| |
− | {{tp|p=32294518|t=2020. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses |pdf=|usr=}}
| |
− | {{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
| |
− | {{ttp|p=31916022|t=2020. Cryo-EM Studies of Virus-Antibody Immune Complexes |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
− | {{tp|p=32451080|t=ä. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization |pdf=|usr=}}
| |
− | {{tp|p=32047128|t=2020. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection |pdf=|usr=}}
| |
− | {{tp|p=C7190498|t=ä. The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650 |pdf=|usr=}}
| |
− |
| |
| *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
− | {{tp|p=32446559|t=2020. Stability of RNA sequences derived from the coronavirus genome in human cells |pdf=|usr=}}
| |
− | {{tp|p=17194611|t=2007. (+)Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle |pdf=|usr=}}
| |
− | {{tp|p=32242128|t=ä. Mechano-genomic regulation of coronaviruses and its interplay with ageing |pdf=|usr=}}
| |
− |
| |
| *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | | |
Zeile 65: |
Zeile 32: |
| | | |
| *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
− | {{tp|p=32198201|t=2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
− | {{tp|p=32452410|t=2020. Association of viral load with serum biomakers among COVID-19 cases |pdf=|usr=}}
| |
| | | |
| *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
− | {{tp|p=32423585|t=2020. Is the HScore useful in COVID-19?|pdf=|usr=}}''index of hyperinflammation''
| |
− | {{tp|p=C7108005|t=ä. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| | | |
| *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
− | {{tp|p=32242089|t=ä. Endocrine and metabolic link to coronavirus infection |pdf=|usr=}}
| |
− | {{tp|p=32382135|t=ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis |pdf=|usr=}}
| |
− | {{tp|p=C7158196|t=2009. 64pp on topic review (+) Molecular Basis of Pulmonary Disease |pdf=|usr=}}
| |
− | {{tp|p=C7197563|t=ä. Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19 |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
− | {{tp|p=31583825|t=2019. Improving immunological insights into the ferret model of human viral infectious disease |pdf=|usr=}}
| |
− | {{tp|p=15892035|t=2005. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus |pdf=|usr=}}
| |
− | {{tp|p=16501078|t=2006. Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro |pdf=|usr=}}
| |
− | {{tp|p=23029269|t=2012. Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model |pdf=|usr=}}
| |
− | {{tp|p=22936401|t=2012. Correlation between TGF??1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain?like protease |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
− | {{tp|p=23821437|t=2013. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium |pdf=|usr=}}
| |
− | {{tp|p=15127935|t=2003. Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus |pdf=|usr=}}
| |
− | {{tp|p=15306390|t=2004. Viral evolution and the emergence of SARS coronavirus |pdf=|usr=}}
| |
− | {{tp|p=31541590|t=2020. Pathogenicity of porcine deltacoronavirus (PDCoV) strain NH and immunization of pregnant sows with an inactivated PDCoV vaccine protects 5?day?old neonatal piglets from virulent challenge |pdf=|usr=}}
| |
− | {{tp|p=30520548|t=2019. Co?localization of Middle East respiratory syndrome coronavirus (MERS?CoV) and dipeptidyl peptidase?4 in the respiratory tract and lymphoid tissues of pigs and llamas |pdf=|usr=}}
| |
− | {{tp|p=32035270|t=ä. Fatal human coronavirus 229E (HCoV-229E) and RSV?Related pneumonia in an AIDS patient from Colombia |pdf=|usr=}}
| |
− | {{tp|p=15381196|t=2004. Cellular entry of the SARS coronavirus |pdf=|usr=}}
| |
− | {{tp|p=15833113|t=2005. Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies |pdf=|usr=}}
| |
− | {{tp|p=16690096|t=2006. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients |pdf=|usr=}}
| |
− | {{tp|p=16678878|t=2006. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 114: |
Zeile 55: |
| | | |
| *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
− | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32423586|t=2020. SARS-CoV-2 and influenza virus co-infection |pdf=|usr=}}
| |
− | {{tp|p=32402687|t=ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
− | {{tp|p=C7190290|t=ä. (On embolism)Progressive respiratory failure in COVID-19: a hypothesis |pdf=|usr=}}
| |
− | {{tp|p=C7177114|t=2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes |pdf=|usr=}}
| |
− | {{tp|p=32376101|t=2020. Association Between Hypoxemia and Mortality in Patients With COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32474397|t=2020. Venous thromboembolism and COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32376225|t=ä. Pulmonary embolism in COVID-19 When nothing is what it seems |pdf=|usr=}}
| |
− | {{tp|p=32407937|t=2020. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China |pdf=|usr=}}
| |
− | {{tp|p=32403032|t=2020. Early thromboembolic events in hospitalized COVID-19 patients |pdf=|usr=}}
| |
− | {{tp|p=32416365|t=2020. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 |pdf=|usr=}}
| |
− | {{ttp|p=32403033|t=2020. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |pdf=|usr=}}
| |
− | {{tp|p=32381264|t=2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis |pdf=|usr=}}
| |
− | {{tp|p=32388068|t=2020. Thrombotic complications in critically ill patients with COVID 19 |pdf=|usr=}}
| |
− | {{tp|p=32291094|t=2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 138: |
Zeile 64: |
| | | |
| *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
− | {{tp|p=32284281|t=2020. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019 |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Heart]]''' | | *'''[[Heart]]''' |
− | {{tp|p=C7184000|t=ä. COVID-19 and cardiogenic shock Different cardiovascular presentations with high mortality |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
− | {{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}}
| |
− | {{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
− | {{tp|p=32402385|t=ä. Manifestaciones cutaneas ... un caso |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
− | {{tp|p=32376072|t=ä. ...gastrointestinales podroman ... |pdf=|usr=}}
| |
− | {{tp|p=32473831|t=ä. Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity |pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
− | {{ttp|p=32204907|t=2020. The Novel Coronavirus 2019 epidemic and kidneys |pdf=|usr=}}
| |
− | {{tp|p=32342401|t=2020. Corona: Starke Vorliebe für die Niere? |pdf=|usr=}}
| |
| | | |
| *'''[[The morbid survivor]]''' | | *'''[[The morbid survivor]]''' |
− | {{tp|p=32372811|t=2020. Concern coronavirus may trigger post-viral fatigue syndromes |pdf=|usr=}}
| |
− | {{tp|p=32402534|t=ä. Sindrome post-cuidados intensivos despuis de la pandemia por SARS-CoV-2 |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
− | {{tp|p=32292226|t=ä. Coronavirus: la emergencia geriatrica de 2020...|pdf=|usr=}}
| |
− | {{tp|p=32418728|t=ä. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection |pdf=|usr=}}
| |
− | {{tp|p=32382258|t=2020. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
− | {{tp|p=32232784|t=ä. A woman with fever and cough: coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32061312|t=2020. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia |pdf=|usr=}}
| |
− | {{tp|p=C7128843|t=ä. A Sever case of of SARS-CoV-2 infection in Gansu |pdf=|usr=}}
| |
− | {{tp|p=32423738|t=ä. Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
Zeile 191: |
Zeile 98: |
| | | |
| *'''[[Case series]]''' | | *'''[[Case series]]''' |
− | {{tp|p=32382448|t=ä. COVID-19 and MERS Infections in Healthcare Workers in Korea |pdf=|usr=}}
| + | |
| | | |
| *'''[[Registries]]''' | | *'''[[Registries]]''' |
− | {{tp|p=32377641|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries |pdf=|usr=}}
| |
− | {{tp|p=32377642|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries ? Authors reply |pdf=|usr=}}
| |
− | {{tp|p=32353329|t=2020. An international registry for emergent pathogens and pregnancy |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Trials]]''' | | *'''[[Trials]]''' |
− | {{tp|p=32292626|t=ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) |pdf=|usr=}}
| |
− | {{tp|p=C7156793|t=2020. COVID-19 randomised trial protocols: rapid publication without barriers |pdf=|usr=}}
| |
| | | |
| *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
− | {{tp|p=32253226|t=ä. (NHC, EIDD-1931) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice |pdf=|usr=}}
| |
− | {{tp|p=32418730|t=ä. ?Off-label? use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers |pdf=|usr=}}
| |
− | {{tp|p=32448638|t=2020. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike |pdf=|usr=}}
| |
− | {{tp|p=32417123|t=ä. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike |pdf=|usr=}}
| |
− | {{tp|p=32387409|t=ä. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France |pdf=|usr=}}
| |
− | {{tp|p=32387694|t=ä. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review |pdf=|usr=}}
| |
− | {{tp|p=32418793|t=2020. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors? CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design |pdf=|usr=}}
| |
− | {{tp|p=32381478|t=2020. Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |pdf=|usr=}}
| |
− | {{tp|p=32452420|t=2020. Antiviral activity of lycorine against Zika virus in vivo and in vitro |pdf=|usr=}}
| |
− | {{tp|p=32292259|t=2020. Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 (Second edition) issued by CAAM |pdf=|usr=}}
| |
− | {{tp|p=32331804|t=ä. Hydroxychloroquine and ?off-label? utilization in the treatment of oral conditions |pdf=|usr=}}
| |
− | {{tp|p=32061923|t=2020. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions |pdf=|usr=}}
| |
− | {{tp|p=32289478|t=2020. Statins in coronavirus outbreak: It?s time for experimental and clinical studies |pdf=|usr=}}
| |
− | {{tp|p=28596841|t=2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |pdf=|usr=}}
| |
− | {{tp|p=32208449|t=2020. BRD4 inhibition exerts anti-viral activity through DNA damage-dependent innate immune responses |pdf=|usr=}}
| |
− | {{tp|p=32355446|t=2020. Medicaments rhumatologiques pour le traitement de l?infection par le COVID-19? |pdf=|usr=}}
| |
− | {{tp|p=32077621|t=2020. Glycyrrhizic?Acid?Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms |pdf=|usr=}}
| |
− | {{tp|p=16043204|t=2005. (+)Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine |pdf=|usr=}}
| |
− | {{tp|p=31930543|t=2020. Inactivation of three emerging viruses ? severe acute respiratory syndrome coronavirus, Crimean?Congo haemorrhagic fever virus and Nipah virus ? in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light |pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| | | |
| *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
− | {{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}}
| |
− | {{tp|p=32388248|t=2020. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces |pdf=|usr=}}
| |
− | {{tp|p=32482249|t=2020. No evidence of severe acute respiratory syndrome?coronavirus 2 in semen of males recovering from coronavirus disease 2019 |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
− | {{tp|p=32294341|t=ä. Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
| *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
− | {{tp|p=32372813|t=2020. Is wearing a face mask a good idea?|pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
− | {{tp|p=32381326|t=ä. ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention |pdf=|usr=}}
| |
− | {{tp|p=32382259|t=2020. Recommendations for a safety dental care management during SARS-CoV-2 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32423627|t=ä. Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle |pdf=|usr=}}
| |
− | {{tp|p=32376131|t=ä. Psychiatry in the aftermath of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32389514|t=ä. International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32382245|t=ä. Comment et pourquoi les rhumatologues sont importants face � la crise du COVID-19�?? |pdf=|usr=}}
| |
− | {{tp|p=32292622|t=ä. Preventing Intra-hospital Infection and Transmission of Coronavirus Disease 2019 in Health-care Workers |pdf=|usr=}}
| |
− | {{tp|p=32382213|t=2020. The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review |pdf=|usr=}}
| |
− | {{tp|p=32389613|t=ä. Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions |pdf=|usr=}}
| |
− | {{tp|p=32389615|t=ä. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research |pdf=|usr=}}
| |
− | {{tp|p=C7111621|t=ä. Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis?|pdf=|usr=}}
| |
− | {{tp|p=32377035|t=ä. ... Maßnahmen an österreichischen Augenabteilungen |pdf=|usr=}}
| |
− | {{tp|p=32389734|t=ä. Spine Surgery in Atlantic Canada in the COVID-19 era: lessons learned so far |pdf=|usr=}}
| |
− | {{tp|p=C7187856|t=2020. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach |pdf=|usr=}}
| |
− | {{tp|p=32482342|t=ä. Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic?|pdf=|usr=}}
| |
− | {{tp|p=32409154|t=2020. COVID-19: A perspective of a frontline worker |pdf=|usr=}}
| |
− | {{tp|p=32417113|t=ä. A quick ?Can I donate blood? self-assessment tool amid the COVID-19 outbreak |pdf=|usr=}}
| |
− | {{tp|p=32386966|t=ä. The blood supply management amid the COVID-19 outbreak |pdf=|usr=}}
| |
− | {{tp|p=32377571|t=2020. eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32418663|t=ä. Cold Plasma, a New Hope in the Field of Virus Inactivation |pdf=|usr=}}
| |
− | {{tp|p=32386875|t=ä. Managing Cancer Care during the COVID-19 Pandemic and Beyond |pdf=|usr=}}
| |
− | {{tp|p=32470381|t=2020. The COVID-19 Pandemic from an Ophthalmologist?s Perspective |pdf=|usr=}}
| |
− | {{tp|p=C7177087|t=2020. Urologic Oncology: News and Topics: Ethics of Urologic Care in the Time of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32380154|t=ä. Personal Protective Equipment for Common Urologic Procedures Before and During the United States COVID-19 Pandemic: A Single Institution Study |pdf=|usr=}}
| |
− | {{tp|p=C7128200|t=ä. Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery |pdf=|usr=}}
| |
− | {{tp|p=32389878|t=ä. Early Report on the Impact of COVID-19 Outbreak in Neurosurgical Practice Among Members of the Latin American Federation of Neurosurgical Societies |pdf=|usr=}}
| |
− | {{tp|p=32389877|t=ä. New Design for Aerosol Protection During Endotracheal Intubation in the Coronavirus Disease 2019 (COVID-19) Pandemic Era: The ?Anti-Aerosol Igloo? (AAI) |pdf=|usr=}}
| |
− | {{tp|p=32387786|t=2020. Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community |pdf=|usr=}}
| |
− | {{tp|p=32380337|t=ä. Neurosurgical Practice During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Worldwide Survey |pdf=|usr=}}
| |
− | {{tp|p=32380338|t=2020. ...Neurosurgery Department, and the Role of Radiosurgery as a Minimally Invasive Procedure for Primary Central Nervous System Lymphoma in the Pandemic Outbreak |pdf=|usr=}}
| |
− | {{tp|p=32380334|t=ä. Impact of the COVID-19 Pandemic on Neurosurgical Residency Training in New Orleans |pdf=|usr=}}
| |
− | {{tp|p=32414670|t=ä. Neurosurgical Training During COVID-19 Pandemic: British Perspective |pdf=|usr=}}
| |
− | {{tp|p=32359151|t=ä. The novel coronavirus and challenges for general and paediatric dentists |pdf=|usr=}}
| |
− | {{tp|p=32344149|t=2020. From cornea to corona |pdf=|usr=}}
| |
− | {{tp|p=32232544|t=ä. Ein Schutz gegen die Tröpfcheninfektion an der Spaltlampe |pdf=|usr=}}
| |
− | {{tp|p=32342174|t=ä. Situation der Deutschen Universitätspathologien... |pdf=|usr=}}
| |
− | {{tp|p=32146248|t=2020. The psychiatric impact of the novel coronavirus outbreak |pdf=|usr=}}
| |
− | {{tp|p=32146245|t=2020. Psychological crisis intervention during the outbreak period of new coronavirus pneumonia from experience in Shanghai |pdf=|usr=}}
| |
− | {{tp|p=32120170|t=2020. Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak |pdf=|usr=}}
| |
− | {{tp|p=32331770|t=ä. Novel Coronavirus and Related Public Health Interventions Are Negatively Impacting Mental Health Services |pdf=|usr=}}
| |
− | {{tp|p=31838479|t=ä. (psych)Remote Treatment Delivery in Response to the COVID-19 Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32205158|t=2020. An integrated response to the impact of coronavirus outbreak on the Emergency Medical Services of Emilia Romagna |pdf=|usr=}}
| |
− | {{tp|p=32334859|t=2020. La m�decine interne dans la pand�mie � SARS-CoV-2 |pdf=|usr=}}
| |
− | {{tp|p=32064701|t=2020. What should virologists be teaching their students?|pdf=|usr=}}
| |
− | {{tp|p=32355444|t=2020. Implications du COVID-19�pour la prise en charge des rhumatismes inflammatoires chroniques? |pdf=|usr=}}
| |
− | {{tp|p=32249763|t=2020. Now, more than ever, our community is needed: spinal cord injury care during a global pandemic |pdf=|usr=}}
| |
− | {{tp|p=32291566|t=ä. Italian society of colorectal surgery recommendations for good clinical practice in colorectal surgery during the novel coronavirus pandemic |pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| | | |
| *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
− | {{tp|p=32387715|t=ä. Addressing Faculty Emotional Responses during the Coronavirus 2019 Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32388173|t=2020. The psychological well-being of physicians during COVID-19 outbreak in Oman |pdf=|usr=}}
| |
− | {{tp|p=32439184|t=ä. COVID-19?Associated Psychiatric Symptoms in Health Care Workers: Viewpoint From Internal Medicine and Psychiatry Residents |pdf=|usr=}}
| |
| | | |
| *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
− | {{tp|p=32389516|t=ä. Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series |pdf=|usr=}}
| |
− | {{ttp|p=32297852|t=ä. Mental health characteristics associated with dysfunctional coronavirus anxiety |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
Zeile 309: |
Zeile 131: |
| | | |
| *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
− | {{tp|p=32454398|t=2020. STEMI during the COVID-19 Pandemic - An Evaluation of Incidence |pdf=|usr=}}
| |
− | {{tp|p=32389608|t=ä. Heart Failure in the COVID-19 Pandemic: Where has all New York s congestion gone?|pdf=|usr=}}
| |
− | {{tp|p=32417567|t=2020. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| | | |
| *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
− | {{ttp|p=32387671|t=2020. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy? |pdf=|usr=}}
| |
− | {{tp|p=C7188145|t=ä. Reporting, Recording and Communication of COVID-19 Cases in Workplace: Data Protection as a Moving Target |pdf=|usr=}}
| |
− | {{tp|p=C7197552|t=ä. Health and safety considerations for hotel cleaners during Covid-19 |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
− | {{tp|p=32299207|t=2020. Global surveillance, travel, and trade during a pandemic |pdf=|usr=}}
| + | |
| | | |
| *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
Zeile 330: |
Zeile 145: |
| | | |
| *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
− | {{tp|p=32402910|t=2020. Possible environmental effects on the spread of COVID-19 in China |pdf=|usr=}}
| |
− | {{tp|p=32402905|t=2020. Changes in air quality related to the control of coronavirus in China: Implications for traffic and industrial emissions |pdf=|usr=}}
| |
− | {{tp|p=32402462|t=ä. Letter to editor regarding Ogen Y 2020 paper: ?Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality? |pdf=|usr=}}
| |
− | {{tp|p=32402464|t=ä. Response to the commentary by Alexandra A Chudnovsky on ?Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality? |pdf=|usr=}}
| |
− | {{tp|p=32388162|t=2020. On airborne transmission and control of SARS-Cov-2 |pdf=|usr=}}
| |
− | {{tp|p=32387822|t=2020. Assessing air quality changes in large cities during COVID-19 lockdowns: The impacts of traffic-free urban conditions in Almaty, Kazakhstan |pdf=|usr=}}
| |
− | {{tp|p=32470687|t=2020. Asymmetric nexus between temperature and COVID-19 in the top ten affected provinces of China: A current application of quantile-on-quantile approach |pdf=|usr=}}
| |
− | {{tp|p=C7191289|t=ä. SARS-CoV-2 in wastewater: State of the knowledge and research needs |pdf=|usr=}}
| |
− | {{tp|p=32388136|t=2020. Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context |pdf=|usr=}}
| |
− | {{tp|p=32413655|t=2020. Does lockdown reduce air pollution? Evidence from 44 cities in northern China |pdf=|usr=}}
| |
− | {{tp|p=32380370|t=2020. COVID-19 pandemic: Impacts on the air quality during the partial lockdown in S�o Paulo state, Brazil |pdf=|usr=}}
| |
− | {{tp|p=32388137|t=2020. Evidence that high temperatures and intermediate relative humidity might favor the spread of COVID-19 in tropical climate: A case study for the most affected Brazilian cities |pdf=|usr=}}
| |
− | {{tp|p=32388159|t=2020. COVID-19 and surface water quality: Improved lake water quality during the lockdown |pdf=|usr=}}
| |
− | {{tp|p=32387821|t=2020. Lockdown, one, two, none, or smart Modeling containing covid-19 infection A conceptual model |pdf=|usr=}}
| |
− | {{tp|p=32388129|t=2020. The nexus between COVID-19, temperature and exchange rate in Wuhan city: New findings from partial and multiple wavelet coherence |pdf=|usr=}}
| |
− | {{tp|p=C7169901|t=2020. Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID |pdf=|usr=}}
| |
− | {{tp|p=32387778|t=2020. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community |pdf=|usr=}}
| |
− | {{ttp|p=C7162772|t=2020. Pollen likely seasonal factor in inhibiting flu-like epidemics A Dutch study into the inverse relation between pollen counts, hay fever and flu-like incidence 2016?2019 |pdf=|usr=}}
| |
− | {{tp|p=32408450|t=2020. Association between ambient temperature and COVID-19 infection in 122 cities from China |pdf=|usr=}}
| |
− | {{tp|p=32408453|t=2020. Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China |pdf=|usr=}}
| |
− | {{tp|p=32380152|t=ä. Potential infectious risk from the pets carrying SARS-CoV-2 |pdf=|usr=}}
| |
− | {{tp|p=C7136945|t=ä. Pangolins Harbor SARS-CoV-2-Related Coronaviruses |pdf=|usr=}}
| |
− | {{tp|p=C7201199|t=ä. Extended urba" width="940" height="350" frameborder="0" scrolling="auto"> tion and the spatialities of infectious disease: Demographic change, infrastructure and governance |pdf=|usr=}}
| |
− | {{ttp|p=C7149709|t=2000.100pp. An Introduction to the Evolutionary Ecology of Viruses |pdf=|usr=}}
| |
− | {{ttp|p=C7149369|t=2000.100pp. Virus Morphology, Replication, and Assembly |pdf=|usr=}}
| |
− | {{ttp|p=24006947|t=2013. Type I IFN Exhaustion is a Host Defence Protecting Against Secondary Bacterial Infections |pdf=|usr=}}
| |
− | {{tp|p=32048160|t=2020. Bat origin of a new human coronavirus: there and back again |pdf=|usr=}}
| |
− | {{tp|p=32251887|t=2020. On biological evolution and environmental solutions |pdf=|usr=}}
| |
− | {{tp|p=32296543|t=2020. Newly identified viral genomes in pangolins with fatal disease |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
− | {{tp|p=C7175784|t=ä. Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 |pdf=|usr=}}
| |
− | {{tp|p=32372785|t=2020. The hunt to find the coronavirus pandemic s patient zero |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
− | {{tp|p=32467013|t=ä. Estimando el n�mero de casos de COVID-19 a tiempo real utilizando un formulario web a trav�s de las redes sociales: Proyecto COVID-19-TRENDS |pdf=|usr=}}
| |
− | {{tp|p=32292691|t=2020. Determining the spatial effects of COVID-19 using the spatial panel data model |pdf=|usr=}}
| |
− | {{tp|p=C7113380|t=ä. On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak |pdf=|usr=}}
| |
− | {{tp|p=32380153|t=ä. Refugees besieged: The lurking threat of COVID-19 in Syrian war refugee camps |pdf=|usr=}}
| |
− | {{tp|p=32363046|t=ä. A new approach to modeling the fade-out threshold of coronavirus disease |pdf=|usr=}}
| |
− | {{tp|p=32303965|t=ä. Association between population migration and epidemic control of Coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32328118|t=2020. Investigating a disease outbreak |pdf=|usr=}}
| |
− | {{tp|p=32293836|t=2020. Quarantine and its legal dimension |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 381: |
Zeile 155: |
| | | |
| *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
− | {{tp|p=32389787|t=ä. Reactivation of COVID-19 pneumonia: A report of two cases |pdf=|usr=}}
| + | |
| | | |
| | | |
Zeile 390: |
Zeile 164: |
| | | |
| *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
− | {{tp|p=C7153724|t=ä. What Are We Talking About?|pdf=|usr=}}''book on post truth communication
| + | |
| | | |
| | | |
| *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
− | {{tp|p=32169251|t=2020. Ophthalmologists Are More Than Eye Doctors?In Memoriam Li Wenliang |pdf=|usr=}}
| |
− | {{tp|p=C7137172|t=2020. Li Wenliang |pdf=|usr=}}
| |
− | {{tp|p=32308229|t=2020. On February 20, Physicians Lost One of Our Greatest Heroes |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
Zeile 405: |
Zeile 175: |
| | | |
| *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
− | {{tp|p=32125418|t=ä. Novel coronavirus (2019-nCoV): Update on 3rd Coronavirus Outbreak of 21st Century |pdf=|usr=}}
| |
− | {{tp|p=32007621|t=2020. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? ? A bibliometric analysis? |pdf=|usr=}}
| |
− | {{tp|p=32288866|t=2020. Verzerrte Informationen: Zwischen Panikmache und Sorglosigkeit |pdf=|usr=}}
| |
− |
| |
| *'''[[misc.]]''' | | *'''[[misc.]]''' |
− | {{tp|p=C7150118|t=2006. Ferrets |pdf=|usr=}}
| |
− | {{tp|p=C7110269|t=ä. COVID-19 Outbreak: an Update on Therapeutic Options |pdf=|usr=}}
| |
− | {{tp|p=C7158368|t=2007. Demyelinating Disorders of the Central Nervous System |pdf=|usr=}}
| |
− | {{tp|p=32387286|t=2020. Wuhan Covid19 data ? more questions than answers |pdf=|usr=}}
| |
− | {{tp|p=C7173534|t=2008. The Structure of Viruses |pdf=|usr=}}
| |
− | {{tp|p=C7150261|t=2008. Subviral Agents |pdf=|usr=}}
| |
− | {{tp|p=C7149993|t=2008. Emerging and Reemerging Viral Diseases |pdf=|usr=}}
| |
− | {{tp|p=C7149408|t=2008. Overview of Viruses and Virus Infection |pdf=|usr=}}
| |
− | {{tp|p=C7150229|t=2008. Minus-Strand RNA Viruses |pdf=|usr=}}
| |
− | {{tp|p=C7149648|t=2008. Plus-Strand RNA Viruses |pdf=|usr=}}
| |
− | {{tp|p=C7117085|t=2020. Neuartiges Coronavirus (SARS-CoV-2) |pdf=|usr=}}
| |
− | {{tp|p=32282586|t=ä. A Local Crash Course in Global Pandemics |pdf=|usr=}}
| |
− | {{tp|p=23356220|t=2013. Tight junction?related human diseases |pdf=|usr=}}
| |
− | {{tp|p=26999792|t=2016. Non-immediate hypersensitivity reactions to beta?lactam antibiotics in children ? our 10?year experience in allergy work?up |pdf=|usr=}}
| |
− | {{tp|p=31025427|t=2019. A review of cutaneous hypersensitivity reactions in infants: From common to concerning |pdf=|usr=}}
| |
− | {{tp|p=32287402|t=2013. Monoclonal antibodies for prophylactic and therapeutic use against viral infections? |pdf=|usr=}}
| |
− | {{tp|p=30226294|t=2018. A novel approach to the diagnosis and treatment of hemoptysis in infants: A case series |pdf=|usr=}}
| |
− | {{tp|p=26252408|t=2015. Dendritic cells: microbial clearance via autophagy and potential immunobiological consequences for periodontal disease |pdf=|usr=}}
| |
− | {{tp|p=32243442|t=2020. Every fifth published metagenome is not available to science |pdf=|usr=}}
| |
− | {{tp|p=32275685|t=2020. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models |pdf=|usr=}}
| |
− | {{tp|p=23238853|t=2013. Evidences for the unfolding mechanism of three?dimensional domain swapping |pdf=|usr=}}
| |
− | {{tp|p=26749402|t=2016. Advancing translational research with next?generation protein microarrays |pdf=|usr=}}
| |
− | {{tp|p=32327859|t=ä. Culture, institutions and democratization* |pdf=|usr=}}
| |
− | {{tp|p=32300262|t=2020. On general principles at the sustainability science-policy interface |pdf=|usr=}}
| |
− | {{ttp|p=32327847|t=2014. ... MERS: Chemical disrupts assembly centers of coronaviruses |pdf=|usr=}}
| |
− | {{tp|p=32328530|t=2018. Nanomaterials-Based Colorimetric Detection of Pathogenic Bacteria and Viruses |pdf=|usr=}}
| |
− | {{tp|p=32268077|t=2020. Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling |pdf=|usr=}}
| |
− | {{tp|p=32327920|t=2010. What can system dynamics learn from the public policy implementation literature?|pdf=|usr=}}
| |
− | {{tp|p=25238620|t=2014. Functional Nanomaterials Can Optimize the Efficacy of Vaccines |pdf=|usr=}}
| |
− | {{tp|p=32077206|t=2020. Novel coronavirus 2019, an emerging public health emergency |pdf=|usr=}}
| |
− | {{tp|p=31373773|t=2019. Rapid identification of human?infecting viruses |pdf=|usr=}}
| |
− | {{tp|p=23926897|t=2013. Transfusion?transmitted emerging infectious diseases: 30 years of challenges and progress |pdf=|usr=}}
| |
− | {{tp|p=31544324|t=2019. Butyrate?producing gut bacteria and viral infections in kidney transplant recipients: A pilot study |pdf=|usr=}}
| |
− | {{tp|p=29423923|t=2018. Stewardship opportunities in viral pneumonia: Why not the immunocompromised?|pdf=|usr=}}
| |
− | {{tp|p=26923867|t=2016. Current practices for treatment of respiratory syncytial virus and other non?influenza respiratory viruses in high?risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative |pdf=|usr=}}
| |
− | {{tp|p=32331807|t=2020. Extraordinary diseases require extraordinary solutions |pdf=|usr=}}
| |
− | {{tp|p=23370150|t=2013. Monoclonal antibodies for prophylactic and therapeutic use against viral infections |pdf=|usr=}}
| |
− | {{ttp|p=31864417|t=2019. Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection |pdf=|usr=}}
| |
− | {{tp|p=32048130|t=ä. Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases |pdf=|usr=}}
| |
− | {{tp|p=30794895|t=2019. Drug repurposing for new, efficient, broad spectrum antivirals |pdf=|usr=}}
| |
− | {{tp|p=20872839|t=2011. Viral nanoparticles and virus?like particles: platforms for contemporary vaccine design |pdf=|usr=}}
| |
− | {{tp|p=21935894|t=2010. Delivery of RNAi mediators |pdf=|usr=}}
| |
− | {{tp|p=32215827|t=ä. Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32166483|t=ä. Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32026147|t=ä. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue |pdf=|usr=}}
| |
− | {{tp|p=32037473|t=ä. New coronavirus: new challenges for pediatricians |pdf=|usr=}}
| |
− | {{tp|p=32107138|t=2020. Neurological Etiologies and Pathophysiology of Cyclic Vomiting Syndrome |pdf=|usr=}}
| |
| | | |
| | | |
| + | *'''[[Research tools]]''' |
| | | |
− |
| |
− | *'''[[Research tools]]''
| |
− | {{tp|p=32256609|t=2020. Organoids as a Powerful Model for Respiratory Diseases |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 471: |
Zeile 188: |
| | | |
| *'''[[PrePrint scene]]''' | | *'''[[PrePrint scene]]''' |
− | *[researchregistry.com reg yor review and basic research paper]
| + | |
| | | |
| *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
− | *[aumbiotech.com rnai self-delivering]
| + | |
− | *[synthego.com crispr cell lines]
| + | |
| *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| *'''[[on-topic personal thoughts]]''' | | *'''[[on-topic personal thoughts]]''' |